62 related articles for article (PubMed ID: 12691600)
1. Reader response to, "Effects of risperidone on aberrant behavior in persons with developmental disabilities: I. A double-blind crossover study using multiple measures".
Levitas A
Am J Ment Retard; 2003 May; 108(3):212-4; author reply 214-6. PubMed ID: 12691600
[No Abstract] [Full Text] [Related]
2. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures.
Zarcone JR; Hellings JA; Crandall K; Reese RM; Marquis J; Fleming K; Shores R; Williams D; Schroeder SR
Am J Ment Retard; 2001 Nov; 106(6):525-38. PubMed ID: 11708938
[TBL] [Abstract][Full Text] [Related]
3. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone on aberrant behavior in persons with developmental disabilities: II. Social validity measures.
McAdam DB; Zarcone JR; Hellings J; Napolitano DA; Schroeder SR
Am J Ment Retard; 2002 Jul; 107(4):261-9. PubMed ID: 12069645
[TBL] [Abstract][Full Text] [Related]
5. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
Simon EW; Blubaugh KM; Pippidis M
Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
[TBL] [Abstract][Full Text] [Related]
6. A crossover study of risperidone in children, adolescents and adults with mental retardation.
Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
[No Abstract] [Full Text] [Related]
8. Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
Onalaja D; Jainer AK
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1076-7; author reply 1077. PubMed ID: 12404659
[No Abstract] [Full Text] [Related]
9. The use of risperidone among individuals with mental retardation: clinically supported or not?
Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
[TBL] [Abstract][Full Text] [Related]
10. Risperidone-induced double incontinence.
Hergüner S; Mukaddes NM
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
[No Abstract] [Full Text] [Related]
11. Self-reported side effects in children and adolescents taking risperidone.
Byrne S; Walter G; Hunt G; Soh N; Cleary M; Duffy P; Crawford G; Krabman P; Concannon P; Malhi G
Australas Psychiatry; 2010 Feb; 18(1):42-5. PubMed ID: 20136533
[TBL] [Abstract][Full Text] [Related]
12. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
[No Abstract] [Full Text] [Related]
13. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
15. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
[TBL] [Abstract][Full Text] [Related]
16. Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis.
Zarcone JR; Lindauer SE; Morse PS; Crosland KA; Valdovinos MG; McKerchar TL; Matthew Reese R; Hellings JA; Schroeder SR
Am J Ment Retard; 2004 Jul; 109(4):310-21. PubMed ID: 15176916
[TBL] [Abstract][Full Text] [Related]
17. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.
Gilbert DL; Batterson JR; Sethuraman G; Sallee FR
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):206-14. PubMed ID: 14726728
[TBL] [Abstract][Full Text] [Related]
18. [Risperidone in the treatment of psychotic disorders associated with mental retardation].
Franco MA; Herraiz M; Martínez MJ; Fernández MC; Conde V
Actas Esp Psiquiatr; 2000; 28(4):251-6. PubMed ID: 11116796
[TBL] [Abstract][Full Text] [Related]
19. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
